Please login to the form below
Truxima
This page shows the latest Truxima news and features for those working in and with pharma, biotech and healthcare.
Daily Brief: Theresa May and the diabetes sensor, Biosimilars hit Roche in Europe, Gilead CEO to step down
period. A number of biosimilar versions of the drug hit European markets last year, including Celltrion's Truxima, (pictured), marketed by Mundipharma and other firms across the region, and this year
Latest news
-
Mundipharma adds breast cancer biosimilar to its portfolio with Celltrion deal
This will be the third biosimilar Mundipharma and Celltrion has launched in the EU, following Remsima (infliximab) and Truxima (rituximab), biosimilars of Johnson and Johnson’s Remicade and Roche’s MabThera. ... With Remsima, we achieved market
-
Roche faces biosimilar blitz in 2018
Novartis’ unit Sandoz and Celltrion/Mundipharma’s Truxima have also claimed a European approval for its biosimilar versions of Roche’s immunotherapy drug MabThera (rituximab).
-
Roche faces prospect of second Rituxan biosimilar in US
It was the second biosimilar of Roche's drug to be approved in Europe after Celltrion/Mundipharma's Truxima, which also pipped Sandoz to the filing post in the US after
-
Standing out in a crowd
It followed that this year by gaining approval from the European Commission for the world’s first monoclonal antibody biosimilar of MabTera (rituximab), marketed as Truxima.
-
WHO pilots scheme to make biosimilars available to poorer countries
Earlier this year the EMA approved Celltrion/Mundipharma's Truxima version of Rituxan, while other biosimilar copies of the drug have started to roll out in India, Latin America, and Russia,
More from news
Approximately 1 fully matching, plus 6 partially matching documents found.
Featured jobs
- Manager - Immunology, Therapeutic Area Communications & Publ...
-
Competitive Salary Offered
-
Senior Account Manager
-
Competitive Salary Offered
-
Account Manager
-
Negotiable
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Business Director
-
Competitive Salary Offered
- Business Development Director – Health Education
-
excellent commission
-
Experienced Medical Writers
-
Competitive Salary and Benefits
- Account Manager- Healthcare Advertising
-
Negotiable
-
Medical Writer
-
Salary TBC
-
Account Director
-
Competitive Salary Offered
-
Medical (Scientific) Director
-
£120, 000 benefits
- Account Manager- Healthcare Advertising
-
Negotiable
-
Systematic Reviewer - Oxford
-
Negotiable
- Senior Account Executive with progression to Account Manager, Me...
-
Excellent package
Subscribe to our email news alerts
- Fishawack acquires Blue Latitude Health
- FDA clears Sandoz and Pear’s Opioid Use Disorder app
- As May delays, industry warns again of ‘no-deal’ Brexit
- Clark Health Communications and Egg digital announce new collaboration
- Axovant drops last ‘legacy’ drug to focus on gene therapies
- Healthcare excellence celebrated at 2018 HSJ Awards
PMHub
Novasecta
We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...
Latest intelligence
- Report: Achieving launch excellence in the challenging healthcare markets of today
- Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
- What is blockchain and why should i care - Richard Springham
- Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
- NHS medicines optimisation milestone
- Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...
Quick links
Infographics
